Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Mitsubishi Tanabe Pharma discloses new TRPM8 agonists for chronic pain

April 8, 2014

Preclinical efficacy of novel PDE10A inhibitors suggests potential for schizophrenia therapy

April 7, 2014

Genzyme to resubmit Lemtrada sBLA in U.S.

April 7, 2014

Glenmark Pharmaceuticals' GRC-27864 enters human trials

April 7, 2014

Daiichi Sankyo and UCSF collaborate on drugs for neurodegenerative diseases

April 7, 2014

Study of RO-5186582 enrolling subjects with Down syndrome

April 4, 2014

Rosetta Genomics and Marina Biotech to develop microRNA products for rare diseases

April 4, 2014

First patient enrolled in phase III trial of clonidine gel for diabetic neuropathy

April 4, 2014

Defense Department grant funds gene therapy study for ALS

April 4, 2014

ReGenX Biosciences and Avexis enter into agreement for NAV rAAV9 vectors

April 3, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.